We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 21

Fighting the counterfeit threat

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • December 20 2013

In the increasingly complex pharmaceutical supply chain, the new regulations to combat the entry of fake or counterfeit medicinal products need to

Don't breach a warranty through failure to fulfil a third party contract

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • May 13 2013

When entering into a contract, one party may be asked to give warranties to the other party relating to a number of different aspects of the state of

The UK Government's changes to the Patents Act makes the UK a more welcoming jurisdiction for clinical trials.

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • February 28 2013

On 26th February, the UK government announced a change to the Patents Act, exempting clinical and field trials as well as health technology

UK private healthcare market referred to Competition Commission

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • May 29 2012

On 4 April, the UK Office of Fair Trading (OFT) referred the market for the provision of privately funded healthcare services to the Competition Commission (CC) for an in-depth investigation, due to concerns over current levels of competition in the sector

Uk supreme Curt decides on industrial applicability in Human Genome Sciences v Eli Lilly and aligns UK jurisprudence with the case law of the EPO Boards of Appeal

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • December 13 2011

The Neutrokine-a dispute which has been pending between Human Genome Sciences (HGS) and Eli Lilly has provided the latest installment in the evolution of UK patent law

Looking at the bigger picture

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • September 1 2011

The pharmaceutical sector is extensively regulated at EU level in order to ensure that the medicinal products manufactured and distributed are safe, effective and of the highest quality

OFT to launch market study into private healthcare

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • December 21 2010

On 14 December 2010, the UK's Office of Fair Trading (OFT) announced that it is to undertake a study of competition in the UK private healthcare market

Pharmaceutical Trademarks 20102011 A Global Guide: United Kingdom

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • September 22 2010

The principal legislation governing trademarks in the United Kingdom is the Trademarks Act 1994

The Association of British Insurers consults on statement of best practice for critical illness cover

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • June 17 2010

The Association of British Insurers (the ABI) has recently published a consultation paper on its statement of best practice for critical illness cover

Northern Ireland to bring back compensation for pleural plaques

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • June 2 2010

The Northern Ireland Executive has published its analysis of the responses to its consultation paper on pleural plaques